TG Therapeutics TGTX Total debt

Total debt at other companies

BiogenBIIB

$7.56B+14.6%

Rhythm Pharmaceuticals, Inc.RYTM

$112.31M-1.1%

Mirum Pharmaceuticals, Inc.MIRM

$12.87M+29.2%

Vor BiopharmaVOR

$2.94M-90.5%

BridgeBio PharmaBBIO

$3.26B+32,101%

Shattuck Labs, Inc.STTK

$2.89M-9.5%

FAQ

What is TG Therapeutics's total debt?

TG Therapeutics (TGTX) reported total debt of $754.44M in Q2 2026.

How has TG Therapeutics's total debt changed year-over-year?

TG Therapeutics's total debt increased by 197.4% year-over-year, from $253.72M to $754.44M.

What is the long-term trend for TG Therapeutics's total debt?

Over 5 years (2020 to 2025), TG Therapeutics's total debt has grown at a 43.3% compound annual growth rate (CAGR), from $41.98M to $253.71M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.